Guidance Documents

Guidance Documents

Component Document Issued Posted ID Topic Overview
Diversion Control Program (DEA) July 28, 2020 July 30, 2020 DEA-DC-044 Controlled Substance Prescriptions

Question and Answer concerning registering with DEA and prescribing controlled substances in more than one state.

Diversion Control Program (DEA) July 13, 2020 July 14, 2020 DEA-DC-042 Controlled Substance Security

Question and answer concerning the bulk destruction of controlled substances during the civil unrest.

Diversion Control Program (DEA) July 6, 2020 July 13, 2020 DEA-DC-041 Controlled Substance Prescriptions

Question and answer concerning a pharmacists ability to dispense controlled substances during civil unrest.

Criminal Division, Criminal - Criminal Fraud Section July 3, 2020 August 4, 2020 CRIMINAL-1315366 Foreign Corruption

The Guide addresses, among other things, who and what is covered by the FCPA's anti-bribery and accounting provisions; the definition of a "foreign official"; what constitute proper and improper gifts, travel and entertainment expenses; the nature of facilitating payments; how successor liability applies in the mergers and acquisitions context; and the hallmarks of an effective corporate compliance program.

Diversion Control Program (DEA) June 12, 2020 June 23, 2020 DEA-DC-040 Controlled Substance Security

Questions and answer concerning pharmacys destruction of damaged controlled substances due to the civil unrest.

Diversion Control Program (DEA) June 10, 2020 June 23, 2020 DEA-DC-038 Controlled Substance Prescriptions

Question and answer concerning controlled substance prescription transfers during civil unrest.

Diversion Control Program (DEA) June 10, 2020 June 23, 2020 DEA-DC-039 Controlled Substance Security

Question and answer addressing what steps  must be taken if a pharmacy is closing permanently due to the civil unrest.

Diversion Control Program (DEA) June 9, 2020 June 10, 2020 DEA-DC-036 General

Question and answer concerning off-site dosing of narcotic treatment program patients during civil unrest.

Diversion Control Program (DEA) June 9, 2020 June 11, 2020 DEA-DC-155 DEA Registration

Question and answer concerning practitioners needing to move controlled substances due to civil unrest and looting.

Diversion Control Program (DEA) June 7, 2020 June 12, 2020 DEA-DC-034 DEA Registration

Question and answer concerning moving controlled substances to another address without changing the address of the DEA registered location.

Diversion Control Program (DEA) June 6, 2020 June 12, 2020 DEA-DC-035 DEA Records and Reports

Question and Answer concerning suspicious order reporting during the civil unrest and looting.

Diversion Control Program (DEA) June 5, 2020 June 12, 2020 DEA-DC157 DEA Records and Reports

Question and answer concerning reporting of theft and/or loss of controlled substances during civil unrest and looting.

Diversion Control Program (DEA) June 4, 2020 June 4, 2020 DEA-DC-031 DEA Registration

Questions and answer concerning obtaining a new DEA registration number for a temporary pharmacy that is replacing a damaged pharmacy due to civil unrest/looting at the same physical address.

National Security Division (NSD) May 27, 2020 April 13, 2021 NSD-1818541 National Security

The guidance discusses the meaning of the term “agent of a foreign principal” as used in FARA.

Diversion Control Program (DEA) April 28, 2020 April 28, 2020 DEA-DC-030 DEA Records and Reports

During the COVID-19 health emergency, DEA will permit OTPs to regularly use off-site locations located in the same state in which they are registered with DEA to deliver take-home doses of buprenorphine to patients authorized to receive them, without separately registering those locations.  OTPs must obtain approval for unregistered delivery locations from local DEA offices and SOTA.

Diversion Control Program (DEA) April 13, 2020 April 13, 2020 DEA-DC-029 General

During the Covid19 Public Health Emergency, DEA will temporarily permit registered practitioners such as hospitals, pharmacies, and physicians to distribute controlled substances (CS) in excess of five percent of their total number of dosage units of CS distributed to other registered dispensers during this calendar year, without registering as a distributor.  All DEA security, recordkeeping and other applicable regulations, including state requirements, remain in effect.

Diversion Control Program (DEA) April 11, 2020 April 11, 2020 DEA-DC-027 General

During the Covid-19 Public Health Emergency, DEA will permit distributors to deliver narcotic substances to Narcotic Treatment Programs without requiring immediate signature by the NTP’s authorized individual accepting delivery.  Distributors must confirm physical possession by the NTP and complete additional recordkeeping requirements in a timely manner.

Diversion Control Program (DEA) April 11, 2020 April 11, 2020 DEA-DC-028 DEA Registration

Due to the Covid-19 Public Health Emergency, DEA-registered hospital/clinics may utilize alternate satellite hospital/clinic locations providing temporary services under their current registrations. DEA will allow such satellite hospitals/clinics to handle controlled substances and to receive shipments of controlled substances directly from distributors.  DEA must be notified by all registered hospital/clinics of any satellite locations intending to handle controlled substances.

Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) April 10, 2020 April 10, 2020 DOJ-1331246 Firearms

Letter to all federal firearms licensees (FFLs) in response to questions from industry members regarding the legality of firearm sales and deliveries exterior to the brick-and-mortar structure at which the firearms business is licensed, in light of the March 13, 2020, declaration of a national emergency concerning the outbreak of the novel coronavirus disease (COVID-19), and the Department of Homeland Security’s subsequent classification of firearms businesses as essential.

Diversion Control Program (DEA) April 10, 2020 June 4, 2020 DEA-DC-032 DEA Records and Reports

Due to the Covid-19 Public Health Emergency, DEA has issued guidance to Distributors to ensure regulatory compliance regarding secure delivery of controlled substance shipments to hospitals, pharmacies and NTPs, documentation and recordkeeping, due diligence requirements, and authorization for emergency alternate distribution sites.

Diversion Control Program (DEA) April 7, 2020 April 7, 2020 DEA-DC-025 General

During the COVID-19 health emergency, DEA will permit OTPs to regularly use off-site locations located in the same state in which they are registered with DEA to deliver take-home doses of methadone to patients authorized to receive them, without separately registering those locations.  OTPs must obtain approval for unregistered delivery locations from local DEA offices and SOTA

Diversion Control Program (DEA) April 5, 2020 April 5, 2020 DEA-DC-026 Controlled Substance Prescriptions

During the COVID-19 public health emergency, DEA-registered hospitals/clinics may conduct remote identity proofing of individual practitioners to issue authentication credentials to eligible practitioners engaged in electronic prescribing of controlled substances, in conformance with existing regulations. DEA suggests using a device that allows for real-time, two-way, audio-visual interactive communication to do so.

Diversion Control Program (DEA) March 31, 2020 March 31, 2020 DEA-DC-022 Controlled Substance Prescriptions

In light of the nationwide public health emergency declared by the HHS on 1-31-20, for the duration of this public health emergency, unless DEA specifies earlier, DEA has establish guidance concerning the use of a telephone call to conduct a telemedicine visit using controlled substances.

Diversion Control Program (DEA) March 31, 2020 March 31, 2020 DEA-DC-023 Controlled Substance Prescriptions

In response to the COVID19 public health emergency(PHE) declared by HHS, the DEA has adopted policies to allow DEA reg. practitioners to prescribe controlled substances(CS) without having to interact in-person with their patients. This chart only addresses prescribing CS and doesn’t address administering or direct dispensing of CS, including by OTPs or hospitals. These go into effect 3-31-20, and will remain in effect for the duration of the PHE, unless DEA specifies an earlier date.

Diversion Control Program (DEA) March 28, 2020 March 28, 2020 DEA-DC-021 Controlled Substance Prescriptions

This is a guidance letter clarifying the circumstances under which oral schedule II prescriptions are permitted and provides temporary exceptions due to the COVID-19 Public Health Emergency declared by the Secretary of Health and Human Services. 

Pages

Was this page helpful?

Was this page helpful?
Yes No